× |
|
A Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Tolerability of High-Dose Quetiapine in Patients With Persistent Symptoms of Schizophrenia or Schizoaffective Disorder PDF |
$40.00 |
|
$40.00 |
× |
           |
Tardive Dyskinesia: Is Vitamin E Singing the Prostate Blues? PDF |
$40.00 |
|
$40.00 |
× |
           |
Sensory Phenomena in Obsessive-Compulsive Disorder and Tourette's Disorder PDF |
$40.00 |
|
$40.00 |
× |
           |
Acute and Long-Term Treatment and Prevention of Relapse of Obsessive-Compulsive Disorder With Paroxetine PDF |
$40.00 |
|
$40.00 |
× |
           |
Long Time, No Sleep: Sleep in Older Adults During the COVID-19 Pandemic PDF |
$40.00 |
|
$40.00 |
× |
           |
Predictors of Persistence of Comorbid Generalized Anxiety Disorder Among Veterans With Major Depressive Disorder PDF |
$40.00 |
|
$40.00 |
× |
           |
Quetiapine-Induced Neuroleptic Malignant Syndrome PDF |
$40.00 |
|
$40.00 |
× |
           |
Association of PTSD and Depression With Medical and Specialist Care Utilization in Modern Peacekeeping Veterans in Canada With Health-Related Disabilities PDF |
$40.00 |
|
$40.00 |
× |
           |
A Double-Blind Comparison of Sertraline and Fluoxetine in Depressed Elderly Outpatients PDF |
$40.00 |
|
$40.00 |
× |
           |
Psychometric Reevaluation of the Columbia-Suicide Severity Rating Scale: Findings From a Prospective, Inpatient Cohort of Severely Mentally Ill Adults PDF |
$40.00 |
|
$40.00 |
× |
           |
Impact of the COVID-19 Pandemic on Child and Adolescent Psychiatric Emergencies PDF |
$40.00 |
|
$40.00 |
|